RAPH Raphael Pharmaceutical Inc.
RAPH financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 6 annual and 0 of 23 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$9.43M (Jun 2025)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
NV
Fiscal Year End
December (1231)
Phone
702-442-1166
EIN
260204284
Headquarters
LAS VEGAS, NV, 89108
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Easy Energy Inc (2007–2021)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-980.00K
Total Assets
$7.00K
Total Equity
$-1.89M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
52%
Return on Assets
-14000%
Current Ratio
0x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| R&D Expense | $631.00K | $776.00K | $569.00K |
| SG&A Expense | $614.00K | $733.00K | $763.00K |
| Operating Income | $-1.25M | $-1.51M | $-1.33M |
| NON-OPERATING INCOME / EXPENSE | |||
| Other Income/Expense | $-34.00K | $-10.00K | $-12.00K |
| Net Income | $-1.28M | $-1.52M | $-1.34M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $0.07 | $0.08 | $0.08 |
| Diluted Shares | 19.55M | 18.67M | 16.72M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $45.00K | $19.00K | $230.00K |
| Accounts Receivable | $2.00K | $2.00K | - |
| Other Current Assets | $6.00K | $6.00K | $7.00K |
| Current Assets | $51.00K | $25.00K | $237.00K |
| PP&E (Net) | $2.00K | $2.00K | $2.00K |
| Intangible Assets | - | - | $2.00K |
| Noncurrent Assets | $2.00K | $2.00K | $2.00K |
| Total Assets | $53.00K | $27.00K | $239.00K |
| LIABILITIES | |||
| Accounts Payable | $163.00K | $125.00K | $69.00K |
| Short-term Debt | - | $41.00K | - |
| Other Current Liabilities (derived) | $297.70K | $603.00K | - |
| Current Liabilities | $1.49M | $769.00K | $132.00K |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $1.49M | $769.00K | $132.00K |
| EQUITY | |||
| Common Stock | $202.00K | $187.00K | $185.00K |
| Additional Paid-in Capital | $8.53M | $7.96M | $7.39M |
| Retained Earnings | $-10.17M | $-8.89M | $-7.37M |
| Total Equity | $-1.43M | $-742.00K | $107.00K |
| Total Liabilities & Equity | $53.00K | $27.00K | $239.00K |
| SUPPLEMENTAL | |||
| Shares Outstanding | 20.18M | 18.70M | 18.50M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-210.00K | $-532.00K | $-1.20M |
| Capital Expenditures | - | - | - |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $236.00K | $321.00K | $1.15M |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $19.00K | $230.00K | $288.00K |
| Net Change in Cash | $26.00K | $-211.00K | $-58.00K |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $45.00K | $19.00K | $230.00K |
| Cash per BS | $45.00K | $19.00K | $230.00K |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $45.00K | $19.00K | $230.00K |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is Raphael Pharmaceutical Inc. profitable?
No. Raphael Pharmaceutical Inc. reported $-980.00K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Fundamentals Hub